Ophtalmic tissue barrier

• US 20040260341A1
• Filed: 08/04/2004
• Published: 12/23/2004
• Est. Priority Date: 08/31/2001
• Status: Abandoned Application

• Current Assignee: Human Technologies
• Original Assignee: Human Technologies
• Inventors: Hays, James C.
• Application Number:
  US10/487,794
• Publication Number:
  US 20040260341A1
• Time in Patent Office: Days
• US Class Current: 606/215
• CPC Class Codes: A61F 2/14 Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
• CPC Class Codes: A61F 2/147 Implants to be inserted in the stroma for refractive correction, e.g. ring-like implants
• CPC Class Codes: A61F 2002/009 for hindering or preventing attachment of biological tissue
• CPC Class Codes: A61F 2002/0091 Having cellular growth inhibitors
• CPC Class Codes: A61F 9/00 Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand caps with means for protecting the eyes A42B1/018; visors for helmets A42B3/22; retractors A61B17/02; manipulators specially adapted for use in surgery A61B34/70; appliances to aid invalids to move about A61H3/00; exercisers for the eyes A61H5/00; eye baths A61H35/02; sunglasses or goggles having the same features as spectacles G02C

Abstract

A tissue barrier (10), for example of titanium alloy, for insertion into an incision in sclera of the eye for the treatment of conditions such as presbyopia, comprises an elongate body which is inert and/or non-reactive in tissue. The barrier can include lateral flanges (14) or not. In a preferred embodiment the barrier has an inverted T-shaped cross-section.

Claims

1. A tissue barrier comprising an elongate body which is non-reactive in tissue and adapted for insertion into an incision in a sclera of an eye to prevent tissue in-growth.

2. A tissue barrier as claimed in claim 1, in which the elongate body is parallelepiped in shape.

3. A tissue barrier as claimed in claim 1, in which the elongate body comprises a longitudinally extending stem portion provided with lateral flanges to prevent the barrier from being ejected from the incision.

4. A tissue barrier as claimed in claim 3, in which the elongate body has a cross-section shaped like an inverted T having a head, with the head of the T providing the flanges.

5. A tissue barrier as claimed in claim 3, in which the lateral flanges extend substantially the full length of the elongate body.

6. A tissue barrier as claimed in claim 3, in which the lateral flanges are in a centre portion only of the elongate body and have a rounded flat shape.

7. A tissue barrier as claimed in claim 3, in which each flange has a thickness about equal to a transverse width of the stem portion.

8. A tissue barrier as claimed in claim 3, in which each flange has a transverse width approximately equal to height of the stem portion.

9. A tissue barrier as claimed in claim 3, in which the barrier has a transverse width of the order of 0.8 mm.

10. A tissue barrier as claimed in claim 3, in which each flange has a thickness of the order of 0.1 mm.

11. A tissue barrier as claimed in claim 3, in which the elongate body has a length of the order of 2.75 mm.

12. A tissue barrier as claimed in claim 3, in which the barrier has a height of the order of 0.5 mm.

15. A method as claimed in claim 13, in which the tissue barrier is a barrier as claimed in claim 1.

16. A method of carrying out ophthalmic surgery comprising utilizing the tissue barrier of claim 1.

13. A method of treating ophthalmic conditions, such as presbyopia, which comprises making a plurality of radial incisions in a sclera of an eye, and inserting an elongate tissue barrier which is non-reactive in tissue into each incision to prevent tissue re-growth.

14. A method as claimed in claim 13, which includes enlarging each radial incision to make incisions of inverted T-shaped cross-section.